Apigenin for Sleep: The Chamomile Compound Explained

TL;DR

Apigenin is a flavonoid found in chamomile, parsley, and celery. It binds the benzodiazepine site on the GABA-A receptor in lab studies, and the two foundational animal papers disagree about what that binding actually does. Nearly all the human sleep and anxiety data on this subject used chamomile extract, not purified apigenin. No published human trial has tested isolated apigenin for sleep.

What apigenin is

Apigenin is a flavone, one of the plant pigments that turn up across the food supply. Chemically it's 5,7,4'-trihydroxyflavone. Chamomile flowers contain it, and so do parsley and celery in larger amounts by weight.

Its reputation comes from chamomile. Dried chamomile flower heads have been brewed as a calming tea for centuries, and when researchers went looking for the compound responsible, apigenin is what they pulled out of the extract (Viola 1995). That's the origin of every claim you'll read about apigenin and sleep.

The receptor story, and why it's messier than it looks

Here's the version you'll see repeated: apigenin binds the same receptor site as benzodiazepines, which is why chamomile calms you down.

The binding part is solid. An Argentine group fractionated an aqueous chamomile extract, isolated apigenin, and showed it competitively inhibited flunitrazepam binding at the central benzodiazepine receptor with a Ki of 4 micromolar. It left muscarinic receptors, alpha-1 adrenoceptors, and muscimol binding at GABA-A alone. In mice, apigenin produced anxiolytic activity on the elevated plus maze at doses comparable to classical benzodiazepines, with no sedation and no muscle relaxation. Push the dose ten times higher and mild sedation appeared, a 26 percent drop in locomotor activity (Viola 1995).

Read that carefully. At the doses that produced an effect, apigenin made mice less anxious without making them sleepy. Sedation only showed up at ten times that.

Five years later an Italian group ran the same kind of experiment and got a different answer. Apigenin again displaced a benzodiazepine-site radioligand. Then the electrophysiology diverged: in cultured cerebellar granule cells, apigenin reduced GABA-activated chloride currents in a dose-dependent way, which is the opposite direction to how a benzodiazepine behaves. It also shortened the time to picrotoxin-induced convulsions. In rats, apigenin reduced locomotor activity but produced no anxiolytic, muscle-relaxant, or anticonvulsant effect. The authors concluded that the sedation they saw could not be attributed to the GABA-A benzodiazepine receptor at all, since a benzodiazepine antagonist failed to block it (Avallone 2000).

So one paper found anxiolysis without sedation, the other found sedation without anxiolysis, and they disagree about whether the benzodiazepine site explains either. Both are receptor-binding and rodent-behavior studies. Neither involved a person.

Anyone presenting the benzodiazepine mechanism as settled is skipping the second paper.

What chamomile trials show, and they tested chamomile

This is the distinction that gets blurred everywhere. The clinical evidence people cite for apigenin was collected using chamomile extract. Chamomile contains apigenin along with dozens of other compounds, and a result from the extract belongs to the extract.

On anxiety, the strongest work comes from a University of Pennsylvania group. Their first trial randomized 57 outpatients with mild to moderate generalized anxiety disorder to chamomile extract or placebo for eight weeks. The chamomile group showed a greater reduction in Hamilton Anxiety Rating scores (p = 0.047), which the authors described as modest anxiolytic activity (Amsterdam 2009).

A larger follow-up gave 179 people 1,500 mg of chamomile extract daily for 12 weeks, then randomized the 93 responders to continue or switch to placebo for 26 weeks. Relapse was less common on chamomile, 15.2 percent against 25.5 percent, and the difference missed statistical significance (hazard ratio 0.52, p = 0.16). The chamomile group did maintain lower anxiety symptoms throughout follow-up (p = 0.0032) (Mao 2016).

On sleep specifically, the picture is weaker. A randomized placebo-controlled pilot gave 34 adults with DSM-IV primary insomnia 270 mg of chamomile extract twice daily for 28 days. There were no differences between groups on total sleep time, sleep efficiency, sleep latency, wake after sleep onset, sleep quality, or number of awakenings. Daytime functioning showed a modest advantage that also fell short of significance (Zick 2011).

Two meta-analyses have pooled the wider literature. The first covered 12 randomized trials and found chamomile improved generalized anxiety scores and sleep quality, while showing no effect on state anxiety across three trials (SMD -0.15, p = 0.42) and noting that a single trial on insomnia found no change in insomnia severity (Hieu 2019).

The second pooled ten chamomile studies in 772 participants. Pittsburgh Sleep Quality Index scores improved (WMD -1.88), with high heterogeneity between studies. Sleep efficiency was unchanged in two studies and worse in one. Daytime functioning measures failed to move in all three studies that assessed them. The authors noted that only one of the ten studies checked the purity or potency of the product it used, and called for objective sleep measures in future work (Kazemi 2024).

Every one of those results describes chamomile.

The absorption problem

A separate question sits underneath all of this. Does apigenin taken by mouth reach your bloodstream in useful amounts?

Two controlled feeding studies suggest the answer is complicated. In one, 18 healthy volunteers ate dried parsley supplying 84 mg of apigenin per day for a week. The researchers reported plainly that plasma apigenin could not be measured (Janssen 1998). In another, 14 subjects on a controlled low-flavone diet were given parsley, and the fraction of apigenin intake recovered in urine came to 0.58 percent (Nielsen 1999).

Those studies used apigenin from food rather than a purified supplement, and analytical methods have improved since. The signal is still worth registering. A compound that binds a receptor in a dish has to reach the receptor first.

What nobody has tested

There is no published human trial of isolated apigenin for sleep. Searching PubMed for apigenin trials in humans returns work on hemostasis, skin aging, oral health, urinary excretion, and chamomile preparations. Nothing on sleep with the purified compound. Nothing on anxiety with the purified compound either.

That absence is the single most useful fact on this page. The dose on an apigenin supplement label was not derived from a sleep trial, because no sleep trial has been run.

Three further gaps. Nobody has compared purified apigenin against chamomile extract head to head. Nobody has established what blood level of apigenin a supplement dose produces. And the human chamomile trials that do exist mostly measured anxiety, with sleep as a secondary outcome or as a self-reported questionnaire score.

How to think about a dose

Supplement doses of apigenin commonly sit around 50 mg, and that figure comes from formulation practice rather than from a trial.

For comparison, the parsley feeding study supplied 84 mg a day and could not detect apigenin in plasma (Janssen 1998). The chamomile trials with the clearest anxiety results used 1,500 mg of extract daily (Mao 2016), and extract is a different thing from the isolated flavone.

If you want the evidence-backed version of this ingredient, chamomile extract at the doses used in the trials has more behind it than purified apigenin does. If you want the compound itself, you're ahead of the research.

For ingredients in this category with more human data, see glycine for sleep and l-theanine dosage for sleep. For the magnesium side, see magnesium glycinate vs citrate and which magnesium is best for sleep and anxiety.

FAQ

How much apigenin should I take for sleep?

No trial has established a dose, because no human sleep trial of isolated apigenin has been published. Typical supplement doses cluster around 50 mg, and that number reflects industry convention. The chamomile trials that showed anxiety benefits used 1,500 mg of whole extract daily (Mao 2016).

Is apigenin the same as chamomile?

Apigenin is one compound in chamomile. Chamomile extract contains apigenin plus many other constituents, and the clinical results were produced by the extract. Treating the two as interchangeable is the most common error in writing about this ingredient.

Does apigenin cause grogginess?

The animal data splits. Mice showed no sedation at anxiolytic doses, with mild sedation appearing only at ten times that (Viola 1995). Rats given apigenin moved around less, though the researchers concluded that effect ran through some pathway other than the benzodiazepine receptor (Avallone 2000). Human grogginess data at supplement doses does not exist. Chamomile trials have reported low rates of adverse events overall (Hieu 2019).

Can you take it with magnesium?

No trial has tested the combination. They act through different routes, and both appear together in commercial sleep formulas, which reflects formulation habit rather than anything tested. The magnesium evidence stands on its own and is stronger.

Should I just drink chamomile tea?

Tea and standardized extract are not the same preparation, and the trials used extract in capsules at measured doses. A pooled analysis found chamomile improved subjective sleep quality scores while leaving sleep efficiency and daytime functioning unchanged (Kazemi 2024). Tea is pleasant, low risk, and part of a wind-down routine that may matter as much as the chemistry.

Disclaimer

This article is for general information only. It is not medical advice and it does not replace guidance from a qualified healthcare professional. Chamomile belongs to the Asteraceae family, and people allergic to ragweed, marigolds, or daisies may react to it. Chamomile may interact with anticoagulant medication. Anyone who is pregnant, breastfeeding, or taking prescription medication should seek medical advice before using chamomile or apigenin supplements. Do not use this information to diagnose or treat any condition. Speak with your doctor before starting any supplement.